These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 14462961)

  • 1. Studies of inhibitory effects of terephthalanilide derivatives against several variants of leukemia L1210.
    LAW LW
    Cancer Chemother Rep; 1962 Jun; 19():13-8. PubMed ID: 14462961
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the effectiveness of 4',4"-di-2-imidazolin-2-ylterephthalanilides against mouse leukemia L1210 and resistant variants.
    VENDITTI JM; GOLDIN A; KLINE I
    Cancer Chemother Rep; 1962 Jun; 19():5-11. PubMed ID: 13925303
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of the effectiveness of Tetramin and its components against advanced leukemia L1210 in mice.
    VENDITTI JM; GOLDIN A; KLINE I
    Cancer Chemother Rep; 1961 Apr; 11():73-6. PubMed ID: 13780696
    [No Abstract]   [Full Text] [Related]  

  • 4. Investigation of the activity of cytoxan against leukemia L1210 in mice.
    VENDITTI JM; HUMPHREYS SR; GOLDIN A
    Cancer Res; 1959 Oct; 19():986-95. PubMed ID: 13841661
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of antileukemic agents employing advanced leukemia L1210 in mice. II.
    GOLDIN A; VENDITTI JM; KLINE I; MANTEL N
    Cancer Res; 1960 Jun; 20(5)Pt 2():382-469. PubMed ID: 13850662
    [No Abstract]   [Full Text] [Related]  

  • 6. The influence of treatment schedule on the chemotheapy of advanced leukemia L1210 in mice.
    VENDITTI JM; GOLDIN A; KLINE I
    Cancer Chemother Rep; 1960 Feb; 6():55-7. PubMed ID: 13841660
    [No Abstract]   [Full Text] [Related]  

  • 7. DISTRIBUTION AND EFFECTS OF 4', 4"-DI(2-IMIDAZOLIN-2-YL)TEREPHTHALANILIDE DIHYDROCHLORIDE HEMIHYDRATE AND ITS 2-CHLORO ANALOGUE IN LYMPHOCYTIC LEUKEMIAS L1210 AND P388.
    SIVAK A; ROGERS WI; WODINSKY I; KENSLER CJ
    J Natl Cancer Inst; 1964 Sep; 33():457-65. PubMed ID: 14207856
    [No Abstract]   [Full Text] [Related]  

  • 8. POTENTIATION OF THE ANTI-LEUKEMIC EFFECTS OF 2-AMINOTHIADIAZOLE BY ISONICOTINAMIDE AND DERIVATIVES.
    OETTGEN HF; PURPLE JR; COLEY VC; KRAKOFF IH; BURCHENAL JH
    Cancer Res; 1964 May; 24():689-92. PubMed ID: 14188475
    [No Abstract]   [Full Text] [Related]  

  • 9. HYDROXYUREA. A NEW TYPE OF POTENTIAL ANTITUMOR AGENT.
    STEARNS B; LOSEE KA; BERNSTEIN J
    J Med Chem; 1963 Mar; 6():201. PubMed ID: 14188794
    [No Abstract]   [Full Text] [Related]  

  • 10. PREVENTION OF ANTILEUKEMIC EFFECT OF TEREPHTHALANILIDE DERIVATIVES IN TRANSPLANTED MOUSE LEUKEMIA P815 BY 4,4'-(TEREPHTHALOYLDIIMINO)DIBENZENESULFONIC ACID DISODIUM SALT (NSC-55156).
    BURCHENAL JH; PURPLE JR; SPOONER EB; BERCHTOLD R; HIRT R; FISCHER R; BALSIGER R
    Cancer Chemother Rep; 1964 Dec; 43():5-10. PubMed ID: 14250654
    [No Abstract]   [Full Text] [Related]  

  • 11. THE CORRELATION BETWEEN TRANSPLANTED MOUSE AND HUMAN ACUTE LEUKEMIAS.
    BURCHENAL JH; OETTGEN HF; LYMAN M; PURPLE J
    Acta Unio Int Contra Cancrum; 1964; 20():256-9. PubMed ID: 14151900
    [No Abstract]   [Full Text] [Related]  

  • 12. Antitumor effect and mode of action of 1-beta-D-arabinofuranosylcytosine 5'-phosphate in leukemia L1210.
    Schrecker AW; Goldin A
    Cancer Res; 1968 Apr; 28(4):802-3. PubMed ID: 5649067
    [No Abstract]   [Full Text] [Related]  

  • 13. STUDIES OF LEUKEMIA L1210 HOMOGRAFT IN SWISS HA-ICR MICE.
    BRADNER WT; BACHMAN S; PINDELL MH
    Cancer Chemother Rep; 1964 Jul; 39():21-39. PubMed ID: 14201273
    [No Abstract]   [Full Text] [Related]  

  • 14. The antimitochondrial action of 2-choloro-4', 4"-bis(2-imidazolin-2-yl)terephthalanilide and methylglyoxal bis(guanylhydrazone).
    Pine MJ; DiPaolo JA
    Cancer Res; 1966 Jan; 26(1):18-25. PubMed ID: 5901744
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of the route of administration on the relative effectiveness of 3',5'-dichloroamethopterin and amethopterin against advanced leukemia (L1210) in mice.
    VENDITTI JM; SCHRECKER AW; MEAD JA; KLINE I; GOLDIN A
    Cancer Res; 1960 Nov; 20():1451-6. PubMed ID: 13780697
    [No Abstract]   [Full Text] [Related]  

  • 16. EXPERIMENTAL EVALUATION OF POTENTIAL ANTICANCER AGENTS. XIII. ON THE CRITERIA AND KINETICS ASSOCIATED WITH "CURABILITY" OF EXPERIMENTAL LEUKEMIA.
    SKIPPER HE; SCHABEL FM; WILCOX WS
    Cancer Chemother Rep; 1964 Feb; 35():1-111. PubMed ID: 14117037
    [No Abstract]   [Full Text] [Related]  

  • 17. OSSAMYCIN, A NEW CYTOTOXIC AGENT.
    SCHMITZ H; JUBINSKI SD; HOOPER IR; CROOK KE; PRICE KE; LEIN J
    J Antibiot (Tokyo); 1965 Mar; 18():82-8. PubMed ID: 14326088
    [No Abstract]   [Full Text] [Related]  

  • 18. SYNTHESIS AND ANTITUMOR ACTIVITY OF 2-AMINO-1-METHYLPURINE- 6-THIONE.
    NOELL CW; SMITH DW; ROBINS RK
    J Med Pharm Chem; 1962 Sep; 5():996-9. PubMed ID: 14056442
    [No Abstract]   [Full Text] [Related]  

  • 19. Further evaluation of the antitumor activity of homofolate and its reduced derivatives against methotrexate-insensitive tumors.
    Mishra LC; Mead JA
    Chemotherapy; 1972; 17(4):283-92. PubMed ID: 4504773
    [No Abstract]   [Full Text] [Related]  

  • 20. Some effects of cyclophosphamide (cytoxan) on normal mice and mice with L1210 leukemia.
    LANE M
    J Natl Cancer Inst; 1959 Dec; 23():1347-59. PubMed ID: 14413840
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.